M&A Deal Summary

electroCore Acquires NeuroMetrix

On December 17, 2024, electroCore acquired medical products company NeuroMetrix

Acquisition Highlights
  • This is electroCore’s 1st transaction in the Medical Products sector.
  • This is electroCore’s 1st transaction in the United States.
  • This is electroCore’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2024-12-17
Target NeuroMetrix
Sector Medical Products
Buyer(s) electroCore
Deal Type Add-on Acquisition

Target

NeuroMetrix

Woburn, Massachusetts, United States
NeuroMetrix is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions, including mobile apps, enterprise software, and cloud-based systems. It operates two commercial brands Quell (wearable neuromodulation platform) and DPNCheck (point-of-care screening test for peripheral neuropathy). NeuroMetrix was founded in 1996 and is based in Woburn, Massachusetts.

Search 201,771 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

electroCore

Rockaway, New Jersey, United States
Category Company
Founded 2005
Sector Medical Products
DESCRIPTION

electroCore is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. electroCore was founded in 2005 and is based in Rockaway, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal